# FDA Warning Letter: Dextrum Laboratories Inc.
> 2023-12-26 · Division of Pharmaceutical Quality Operations II · `1d317a22d7f162ae`
## Letter
- **Company:** Dextrum Laboratories Inc.
- **Posted Date:** 2023-12-26
- **Letter Issue Date:** 2023-12-07
- **Issuing Office:** Division of Pharmaceutical Quality Operations II
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*